TCL Archive After Congressional Inquiry, NCI Posts Ambiguous Statement On Abortion And Breast Cancer Risk December 13, 2002
TCL Archive FDA Approves Abraxane For Second-Line Treatment Of Metastatic Breast Cancer January 28, 2005